Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia

OBJECTIVES: Teicoplanin, a glycopeptide, is regarded as among the drug choices for methicillin-resistant Staphylococcus aureus (MRSA) infections. Few studies have evaluated the relationship between teicoplanin minimal inhibitory concentrations (MICs) and outcomes among patients with serious MRSA inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ching-Yen, Lee, Chen-Hsiang, Chien, Chun-Chih, Chen, I-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101025/
https://www.ncbi.nlm.nih.gov/pubmed/30147349
http://dx.doi.org/10.2147/IDR.S171236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101025/
https://www.ncbi.nlm.nih.gov/pubmed/30147349
http://dx.doi.org/10.2147/IDR.S171236

Ejemplares similares